These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12901963)

  • 21. Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
    Galsky MD; Pal SK; Chowdhury S; Harshman LC; Crabb SJ; Wong YN; Yu EY; Powles T; Moshier EL; Ladoire S; Hussain SA; Agarwal N; Vaishampayan UN; Recine F; Berthold D; Necchi A; Theodore C; Milowsky MI; Bellmunt J; Rosenberg JE;
    Cancer; 2015 Aug; 121(15):2586-93. PubMed ID: 25872978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palliative chemotherapy in advanced bladder cancer.
    Roth BJ
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):10-5. PubMed ID: 7537896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to treatment of metastatic bladder cancer.
    Edelman MJ
    Curr Oncol Rep; 2000 Sep; 2(5):379-85. PubMed ID: 11122868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer.
    Kaneko G; Kikuchi E; Matsumoto K; Obata J; Nakamura S; Miyajima A; Oya M
    Jpn J Clin Oncol; 2011 Jul; 41(7):908-14. PubMed ID: 21665907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for advanced bladder carcinoma: new molecules and regimens.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):43-5. PubMed ID: 8701810
    [No Abstract]   [Full Text] [Related]  

  • 27. Progress in the management of metastatic bladder cancer.
    Parimoo D; Raghavan D
    Cancer Control; 2000; 7(4):347-56. PubMed ID: 10895129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of taxanes in the management of bladder cancer.
    Galsky MD
    Oncologist; 2005; 10(10):792-8. PubMed ID: 16314289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of metastatic urothelial cancer in the post-MVAC era.
    Cohen EE; Stadler WM
    World J Urol; 2001 Apr; 19(2):126-32. PubMed ID: 11374315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancers.
    Matsui Y; Nishiyama H; Yoshimura K; Xing ND; Sumiyoshi T; Saito R; Inoue T; Kamba T; Ogawa O
    Int J Clin Oncol; 2013 Apr; 18(2):321-8. PubMed ID: 22410820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.
    Fairey AS; Daneshmand S; Quinn D; Dorff T; Dorin R; Lieskovsky G; Schuckman A; Cai J; Miranda G; Skinner EC
    Urol Oncol; 2013 Nov; 31(8):1737-43. PubMed ID: 23141776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine and cisplatin in locally advanced and/or metastatic bladder cancer.
    von der Maase H
    Eur J Cancer; 2000 Jul; 36 Suppl 2():13-6. PubMed ID: 10908843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
    Ravi P; Pond GR; Diamantopoulos LN; Su C; Alva A; Jain RK; Skelton WP; Gupta S; Tward JD; Olson KM; Singh P; Grunewald CM; Niegisch G; Lee JL; Gallina A; Bandini M; Necchi A; Mossanen M; McGregor BA; Curran C; Grivas P; Sonpavde GP
    BJU Int; 2021 Nov; 128(5):607-614. PubMed ID: 33909949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine in advanced bladder cancer.
    von der Maase H
    Semin Oncol; 2001 Apr; 28(2 Suppl 7):11-4. PubMed ID: 11372046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of renal function of patients with advanced urothelial cancer on eligibility for first-line chemotherapy and treatment outcomes.
    Ichioka D; Miyazaki J; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Nishiyama H
    Jpn J Clin Oncol; 2015 Sep; 45(9):867-73. PubMed ID: 26056328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium.
    Bellmunt J; Albiol S; de Olano AR; Pujadas J; Maroto P;
    Ann Oncol; 2006 May; 17 Suppl 5():v113-7. PubMed ID: 16807437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moving forward in advanced bladder cancer.
    Vaughn DJ
    J Clin Oncol; 2007 Jun; 25(16):2162-3. PubMed ID: 17538159
    [No Abstract]   [Full Text] [Related]  

  • 38. Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma.
    Matsumoto K; Irie A; Satoh T; Okazaki M; Iwamura M; Baba S
    Int J Urol; 2007 Nov; 14(11):1000-4; discussion 1004. PubMed ID: 17956525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Place of chemotherapy in the treatment of invasive bladder tumors].
    Pariente JL; Theodore C; Davin JL; Rischmann P; Chopin D
    Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).
    Bamias A; Dafni U; Karadimou A; Timotheadou E; Aravantinos G; Psyrri A; Xanthakis I; Tsiatas M; Koutoulidis V; Constantinidis C; Hatzimouratidis C; Samantas E; Visvikis A; Chrisophos M; Stravodimos K; Deliveliotis C; Eleftheraki A; Pectasides D; Fountzilas G; Dimopoulos MA
    Ann Oncol; 2013 Apr; 24(4):1011-7. PubMed ID: 23136231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.